Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Total 13F shares
-
13,910,388
-
Share change
-
+288,274
-
Total reported value
-
$10,533,734
-
Put/Call ratio
-
18%
-
Price per share
-
$0.76
-
Number of holders
-
50
-
Value change
-
-$288,922
-
Number of buys
-
11
-
Number of sells
-
41
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q3 2024
As of 30 Sep 2024,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,910,388 shares.
The largest 10 holders included
Bleichroeder LP, Slate Path Capital LP, VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, Robertson Stephens Wealth Management, LLC, Sigma Planning Corp, Good Life Advisors, LLC, MILLENNIUM MANAGEMENT LLC, and GSA CAPITAL PARTNERS LLP.
This page lists
50
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.